MentionFox
Osseus appears in Y Combinator's company directory in the Summer 2026 batch, listed 2026-07-11.
Osseus is a Y Combinator company in the Summer 2026 batch. The founders listed are Anish Mariathasan (Founder/CEO), Ayush Patel (Founder/CTO) (Y Combinator directory entry, July 11, 2026).
Sell to companies like Osseus? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2026-07-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Osseus.
Free to see. No signup.
We'll show it in your MentionFox inbox when Osseus raises, hires or launches. No email unless you switch it on.
Watch Osseus →Get the full cited report on Osseus
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Osseus: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Read from the page's own HTML and response headers on 10 September 2026, at https://www.osseus.ai/. Each badge matched a string the site serves about itself — hover one to see which. Nothing here is a traffic, ranking or revenue figure: those cannot be read off a page and are not claimed.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
Medical and biological datasets and RL environments for research labs. An AI-native EHR, with custom models inside it, for hospitals and clinics.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Co-Founder at Osseus (YC S26). Prev. co-founded a compliance AI startup. ML research at a Harvard-HKU joint lab on computer vision for cancer research. MEng in Biomedical Engineering from Imperial College London, dropped Oxford PhD in AI for Health. Awarded academic scholarships for both.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Osseus: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Osseus covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist OsseusYou get an alert in MentionFox the next time this company shows up.
If you're behind Osseus: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, and from the company's own site, read directly on 2026-09-06 (osseus.ai).
Each opens in a new tab, filled in for Osseus. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/yc-osseus